SOURCE: Signal Watch

Signal Watch

April 05, 2012 08:20 ET

Analytical Reports on DaVita Inc. and HEALTHSOUTH Corp. - Specialized Health Services Looking to Expansion to Escape Reform

NEW YORK, NY--(Marketwire - Apr 5, 2012) - www.SignalWatcher.com provides members with proprietary analysis of over 10,000 stocks which is updated every day. Today, members can receive their complimentary stock analysis on DaVita Inc. (NYSE: DVA) and HEALTHSOUTH Corp. (NYSE: HLS). Sign up now on www.SignalWatcher.com to get your free reports on these stocks.

Although it is still unclear to what extent companies in the Specialized Health Services industry, such as DaVita Inc. and HEALTHSOUTH Corp., will be impacted, health care reforms remain a concern. Many industry players currently derive significant portions of their income from the Medicare program, and moving forward there is a good chance these reimbursements will be cut, effecting revenue. www.SignalWatcher.com gives traders a unique insight about DaVita Inc. and HEALTHSOUTH Corp. by registering now at http://signalwatcher.com/DVA/April052012.php or http://signalwatcher.com/HLS/April052012.php.

www.SignalWatcher.com brings investors free classic analysis on DaVita Inc., HEALTHSOUTH Corp. and other companies within the Specialized Health Services industry. This type of analysis is only a fragment of the information members have available to them. To learn more we encourage investors to sign up at http://signalwatcher.com/EmailSignup.php.

Furthermore, the reform will likely cause a reduction in the number of policyholders choosing commercial insurance and push those staying with commercial insurance into policies with more limited benefits. Both these trends will likely drag down reimbursement rates and, by extension, earnings.

Many industry players are thus looking to expand their reach and revenue streams into new markets. Emerging and developing markets are especially promising as their potential for growth far exceeds that of mature markets. DaVita recently announced a joint venture with leading Chinese biotechnology company 3SBio Inc. This follows new deals expanding the company's presence in India and Southeast Asia.

About Signal Watch

Signal Watch's #1 goal is to help customers successfully engage the markets. For over 20 years, we have been developing the most powerful trading software available anywhere. But the software is only part of our mission. We also provide education and customer support designed to enable our customers to take control of their financial future.

Read our disclaimer by clicking on the following link http://www.signalwatcher.com/disclaimers.php

Contact Information